SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-019702
Filing Date
2021-08-12
Accepted
2021-08-12 16:15:18
Documents
17
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20210604_8k.htm 8-K 27715
2 EXHIBIT 99.1 ex_255469.htm EX-99.1 158068
3 EXHIBIT 99.2 ex_255470.htm EX-99.2 8106
4 kplogo.jpg GRAPHIC 13939
5 slide1.jpg GRAPHIC 50793
6 slide2.jpg GRAPHIC 257422
7 slide3.jpg GRAPHIC 46631
8 slide4.jpg GRAPHIC 170075
9 slide5.jpg GRAPHIC 180210
10 slide6.jpg GRAPHIC 122565
11 slide7.jpg GRAPHIC 171152
12 slide8.jpg GRAPHIC 23061
13 slide9.jpg GRAPHIC 170474
14 slide10.jpg GRAPHIC 142715
15 slide11.jpg GRAPHIC 147528
16 slide12.jpg GRAPHIC 134361
17 slide13.jpg GRAPHIC 45721
  Complete submission text file 0001437749-21-019702.txt   2505622
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 211167746
SIC: 2834 Pharmaceutical Preparations